Disclosure Of Interests In Other Entities [Text Block]

Pharming Group N.V. - Filing #1883078

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Disclosure of interests in other entities [text block]
Investments
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
The following table provides an overview of the consolidated subsidiaries at
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets
277,500,000 USD
249,444,000 USD
Non-current assets
148,297,000 USD
147,871,000 USD
Current liabilities
59,698,000 USD
46,771,000 USD
Non-current liabilities
161,461,000 USD
157,628,000 USD
Revenue
205,622,000 USD
198,871,000 USD
Profit (loss)
USD
USD
13,674,000 USD
USD
13,674,000 USD
USD
USD
USD
15,996,000 USD
15,996,000 USD
Comprehensive income
USD
11,054,000 USD
2,620,000 USD
USD
13,674,000 USD
USD
17,085,000 USD
USD
1,089,000 USD
15,996,000 USD
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income
USD
11,054,000 USD
11,054,000 USD
USD
USD
USD
17,085,000 USD
USD
17,085,000 USD
USD
Investments accounted for using equity method
2,501,000 USD
7,201,000 USD
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
207,342,000 USD
191,924,000 USD
205,159,000 USD
Other non-current financial liabilities
USD
165,000 USD
Tax expense (income)
1,313,000 USD
7,082,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.